Zhangjiagang

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• COPD1 trial
• Liver and biliary tract cancer1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• AstraZeneca3 trials

Running trials

• Recruiting

  A Multicentre, Single Arm, Non-interventional, Real-world Study to Assess Demographic Characteristics and Patient Reported Outcomes in Patients With Severe Eosinophilic Asthma Treated With Benralizumab in China

  NCT06862206· AstraZeneca· Source

• Active, not recruiting

  Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With uHCC

  NCT05557838· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting
• COPD1 recruiting

Closed trials

• Completed

  A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

  NCT06422663· AstraZeneca· Source